Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of ...

Taking semaglutide may lead to a slight increase in heart rate — typically by two to three beats per minute, based on trials sponsored by Novo Nordisk using 0.5 and 1 mg doses of semaglutide.

Almost 200 of the diabetes patients were prescribed semaglutide and 17 went on to develop NAION, a rate more than four times higher than those not prescribed the drug. For the obesity group, 361 ...

Compounded semaglutide is a non-FDA-approved alternative to products that contain semaglutide, such as Ozempic. Learn how the safety and efficacy of compounded semaglutide compares with Ozempic.

When it comes to semaglutide, withdrawal symptoms can involve changes related to weight, appetite, blood sugar levels, and cardiovascular health. When you regularly take a medication that alters ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with ...

If all newly eligible patients received semaglutide, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research. Published Aug. 27, 2024 ...

Semaglutide treatment was initiated at a dose of 0.25 mg for 4 weeks, and the dose was escalated every 4 weeks until the maintenance dose of 2.4 mg was reached by week 16 (Fig. S1).

In its declaratory order on semaglutide, FDA clarified that it will exercise enforcement discretion for 503A compounding pharmacies until April 22, 2025, and 503B outsourcing facilities until May ...